All data are based on the daily closing price as of October 4, 2024
v
Vuno
338220.KQ
25.83 USD
0.57
+2.26%
Overview
Last close
25.83 usd
Market cap
358.67M usd
52 week high
49.08 usd
52 week low
12.34 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
28.2041
Price/Book Value
50.6729
Enterprise Value
343.13M usd
EV/Revenue
22.5101
EV/EBITDA
-9.7142
Key financials
Revenue TTM
12.72M usd
Gross Profit TTM
1.43M usd
EBITDA TTM
-10.31M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
29.17B usd
Net debt
5.06B usd
About
Vuno Inc. operates as a medical artificial intelligence (AI) solution development company. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. Its products include BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalities in the fundus of the eye; and LungCT AI, an AI-based pulmonary lung nodule detection and reporting system. The company was founded in 2014 and is headquartered in Seoul, South Korea.